Bio Reports
Lunit AI Cuts Radiologist Workload by 50% While Predicting Cancer Risk Up to Six Years in Advance, New Studies Show
Two new studies show Lunit INSIGHT MMG cuts radiologist workload by 50% in a double reading environment while maintaining or improving screening qua...
October 24, 2024 | News
Minghui Pharmaceutical Reports Positive Results from Phase Ib/II Trial of MHB018A in Thyroid Eye Disease Patients
Minghui Pharmaceutical, Inc., a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, ann...
October 23, 2024 | News
Why Singapore is the World’s New Pharma Powerhouse: Unpacking the Secrets Behind Its Manufacturing Boom
Singapore’s pharmaceutical revolution: How data and digital transformation are fueling a global hub Once primarily recognized for it...
October 22, 2024 | Opinion | By Venkatesh Arunachalam, General Manager of the Life Science Manufacturing group at Cognizant
APAC Liver Disease Alliance and Thailand's Ministry of Public Health Launch "Hep-Free 2030" Summit to Tackle Viral Hepatitis in Asia
The APAC Liver Disease Alliance, in collaboration with Thailand's Department of Disease Control, Ministry of Public Health, kicks off the Allianc...
October 03, 2024 | News
Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
The Hong Kong Breast Cancer Registry (HKBCR), run by the Hong Kong Breast Cancer Foundation (HKBCF), launched its 16th annual research report&nbs...
September 30, 2024 | News
Cardiovascular Health Inequity for Women in the Asia-Pacific: A Call for Action
Kearney, a leading management consulting firm, has released a comprehensive report titled "Cardiovascular Health Inequity for Women in the Asia Pacif...
September 25, 2024 | Report
Singapore Researchers Pioneer Technique to Rejuvenate Aged Egg Cells, Boosting IVF Success for Older Women
Researchers from the Mechanobiology Institute (MBI) at the National University of Singapore (NUS) and the NUS Bia-Echo Asia Centre...
September 20, 2024 | News
Johnson & Johnson’s TAR-200 Shows Promising Results in BCG-Unresponsive Bladder Cancer in Latest Phase 2b SunRISe-1 Study
Johnson & Johnson announced additional results from its pivotal Phase 2b SunRISe-1 study, reinforcing the safety and efficacy of TAR-200, an investigat...
September 16, 2024 | News
Australia Faces Urgent Call to Address Childhood Dementia Crisis in New 2024 Report
A groundbreaking new report, "State of Childhood Dementia in Australia 2024," released at Australia's Parliament House in Ca...
September 10, 2024 | Report
Novotech Releases Comprehensive Report on Global Clinical Trial Landscape for Gastric Cancer, Highlighting Key Trends and Therapeutic Advances
Novotech, the leading global full-service clinical Contract Research Organization (CRO) specializing in partnering with biotech companies to accelerate the...
September 05, 2024 | Report
Gender Disparities and Adherence Challenges Uncovered in Cardiovascular Disease Care: New Insights from Daiichi Sankyo
ifferences in cardiovascular disease (CVD) care have been identified, impacting clinical outcomes: There are gender differences in CVD care, spe...
September 03, 2024 | News
New Trials, New Pills—The Pharma Rollercoaster Continues!
The Landscape of Innovation: A Double-Edged Sword The pace at which pharmaceutical companies are developing new drugs is nothing short of astonish...
August 30, 2024 | Report
HKBU Research Identifies Phosphocholine as a Potential Therapy for PM2.5-Related Lung Damage
A research team led by Hong Kong Baptist University (HKBU) has discovered that phosphocholine, an important component in the body's metabolism, c...
August 28, 2024 | News
Mabwell Receives NMPA Approval to Initiate Phase III Study of 9MW2821 in Recurrent or Metastatic Cervical Cancer
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (C...
August 26, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
